The Benefits and Harms of Systemic Dehydroepiandrosterone (DHEA) in Postmenopausal Women With Normal Adrenal Function: A Systematic Review and Meta-analysis
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Context: Exogenous dehydroepiandrosterone (DHEA) therapy has been proposed to replenish the depletion of endogenous DHEA and its sulfate form, which occurs with advancing age and is thought to be associated with loss of libido and menopausal symptoms. Objective: We conducted a systematic review and meta-analysis to summarize the evidence supporting the use of systemic DHEA in postmenopausal women with normal adrenal function. Methods: We searched MEDLINE, EMBASE, PsycInfo, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus through January 2014. Pairs of reviewers, working independently, selected studies and extracted data from eligible randomized controlled trials (RCTs). We used the random-effects model to pool across studies and evaluated heterogeneity using the I2 statistic. Results: We included 23 RCTs with moderate to high risk of bias enrolling 1188 women. DHEA use was not associated with significant improvement in libido or sexual function (standardized mean difference, 0.35; 95% confidence interval, −0.02 to 0.73; P value = .06; I2 = 62%). There was also no significant effect of DHEA on serious adverse effects, serum lipids, serum glucose, weight, body mass index, or bone mineral density. This evidence warranted low confidence in the results, mostly due to imprecision, risk of bias, and inconsistency across RCTs. Conclusions: Evidence warranting low confidence suggests that DHEA administration does not significantly impact sexual symptoms or selected metabolic markers in postmenopausal women with normal adrenal function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systemic DHEA is not associated with significant improvement in libido or sexual function in postmenopausal women with normal adrenal function and cannot be recommended for women with HSDD 18 (Level IA, Grade A).”
From Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019) · cites this paper as [18]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 3×
“Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing.”
MethodInfluentialPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 2×
“Between-study inconsistency was measured by I(2) statistics, which estimate the proportion of variation in results across studies that is not due to chance (19).”
BackgroundMethodPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 3×
“Statistical analysis Meta-analysis was done using random effect meta-analysis described by DerSimonian and Laird (22) to account for the The Endocrine Society.”
MethodInfluentialSterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 2×
“Publication bias Due to the small number of studies per each outcome, methods to detect publication bias could not be applied because these methods usually require at least 10 to 20 studies to reliably test for bias (23, 25).”
MethodAssessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396 · cited 1×
“Methodological quality and risk of bias assessment Two reviewers independently assessed the quality of each RCT using the Cochrane Risk of Bias assessment tool (20).”
MethodThe case of the misleading funnel plot
Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006) · BMJ · doi:10.1136/bmj.333.7568.597 · Cited by 1,766 · cited 1×
“Publication bias Due to the small number of studies per each outcome, methods to detect publication bias could not be applied because these methods usually require at least 10 to 20 studies to reliably test for bias (23, 25).”
MethodORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349 · cited 1×
“The reduction in DHEAS is more prominent than that of T (2).”
BackgroundAndrogen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy
Davison, S. L., Bell, R., Donath, S., Montalto, J. G., & Davis, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0212 · Cited by 998 · cited 6×
“(J Clin Endocrinol Metab 99: 3536–3542, 2014) As women advance in age, they experience a decline inT and dehydroepiandrosterone sulfate (DHEAS) (1).”
BackgroundInfluentialEffects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841 · cited 1×
“Morales, 1994 (8) United States, academic hospital 17 Healthy perimenopausal”
BackgroundBaulieu, E.-E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M.-P., Latour, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4279 · Cited by 577
DHEA in elderly women and DHEA or testosterone in elderly men.
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054629 · Cited by 566 · cited 2×
“placebo Nair, 2006 (14) United States, academic hospital 57 Elderly postmenopausal”
BackgroundCirculating Androgen Levels and Self-reported Sexual Function in Women
Davis, S. R. (2005) · JAMA · doi:10.1001/jama.294.1.91 · Cited by 510
Morales, A. J., Haubrich, R. H., Hwang, J. Y., Asakura, H., & Yen, S. S. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00507.x · Cited by 418 · cited 2×
“Morales, 1998 (16) United States, academic hospital 10 Healthy nonobese,”
BackgroundThe effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · cited 1×
“The quality of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methods (21).”
MethodSelf-citationDehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
Schmidt, P. J., Daly, R. C., Bloch, M., Smith, M. J., Danaceau, M. A., Simpson St. Clair, L., Murphy, J. H., Haq, N., & Rubinow, D. R. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.154 · Cited by 254 · cited 1×
“Some of these trials showed a beneficial effect of DHEA on sexual function (6–11), whereas others found no positive effect (12, 13).”
BackgroundWolf, O. T., Neumann, O., HELLHAMMER, D. H., Geiben, A. C., Strasburger, C. J., Dressendörfer, R. A., Pirke, K.-M., & Kirschbaum, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4056 · Cited by 231 · cited 1×
“Wolf, 1997 (11) Germany, academic hospital 15 Healthy postmenopausal”
BackgroundLabrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.-L., Girard, G., Baron, M., Ayotte, N., Moreau, M., et al. (2009) · Menopause · doi:10.1097/gme.0b013e31819e85c6 · Cited by 191 · cited 1×
“Menopausal symptoms assessed by the Menopause-Specific Quality of Life Questionnaire (MENQOL) showed no improvement when oral DHEA was compared to placebo (10), whereas the sexual domain score of the same questionnaire showed improvement when vaginal DHEA was studied in women with vaginal atrophy in a different study…”
MethodCasson, P. R., Santoro, N., Elkind-Hirsch, K., Carson, S. A., Hornsby, P. J., Abraham, G., & Buster, J. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00121-6 · Cited by 174 · cited 1×
“The same conflicting results have been reported for the effect of DHEA on bone health as assessed by BMD because some studies revealed beneficial effects (6, 12, 14) whereas others did not (15, 16).”
BackgroundBarnhart, K. T., Freeman, E., Grisso, J. A., Rader, D. J., Sammel, M., Kapoor, S., & Nestler, J. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6153 · Cited by 165
Wolf, O. T. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2363 · Cited by 163
DHEA Replacement for Postmenopausal Women
Davis, S. R., Panjari, M., & Stanczyk, F. Z. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2888 · Cited by 139 · cited 1×
“A more recent literature review conducted by Davis et al (26) in 2011 concluded that oral DHEA did not show any benefit with regard to impaired sexual function, well-being, and cognitive performance in postmenopausal women.”
MethodKenny, A. M., Boxer, R. S., Kleppinger, A., Brindisi, J., Feinn, R., & Burleson, J. A. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03019.x · Cited by 125 · cited 1×
“Kenny, 2010 (36) United States, major medical”
Jankowski, C. M., Gozansky, W. S., Schwartz, R. S., Dahl, D. J., Kittelson, J. M., Scott, S. M., Van Pelt, R. E., & Kohrt, W. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2484 · Cited by 111 · cited 1×
“Jankowski, 2006 (35) United States, academic hospital 70 Healthy postmenopausal”
Backgroundvon Mühlen, D. G., Laughlin, G. A., Kritz‐Silverstein, D. C., Bergstrom, J., & Bettencourt, R. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0520-z · Cited by 104 · cited 1×
“von Mühlen, 2008 (40) United States, academic hospital 115 Healthy postmenopausal”
BackgroundMetabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women
Lasco, A., Frisina, N., Morabito, N., Gaudio, A., Morini, E., Trifiletti, A., Basile, G., Nicita-Mauro, V, & Cucinotta, D. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450457 · Cited by 104 · cited 1×
“Lasco, 2001 (37) Italy, academic hospital 20 Healthy adrenal-”
Role of androgens in women's sexual dysfunction
Basson, R., Brotto, L. A., Petkau, A. J., & Labrie, F. (2010) · Menopause · doi:10.1097/gme.0b013e3181d59765 · Cited by 97 · cited 1×
“trol study conducted in 2010 further supported these findings and highlighted this association (4).”
ResultDHEA for postmenopausal women: A review of the evidence
Panjari, M., & Davis, S. R. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.12.017 · Cited by 97 · cited 8×
“Panjari M, Bell RJ, Jane F, Adams J, Morrow C, Davis SR.”
BackgroundInfluentialKritz‐Silverstein, D., Von Mühlen, D., Laughlin, G. A., & Bettencourt, R. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01768.x · Cited by 92 · cited 1×
“Kritz-Silverstein, 2008 (7) United States, clinical research”
Acute Dehydroepiandrosterone (DHEA) Effects on Sexual Arousal in Postmenopausal Women
Hackbert, L., & Heiman, J. R. (2002) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460902753645290 · Cited by 82 · cited 2×
“Some of these trials showed a beneficial effect of DHEA on sexual function (6–11), whereas others found no positive effect (12, 13).”
BackgroundReplacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women
Casson, P. R., Faquin, L. C., Stentz, F. B., Straughn, A. B., Andersen, R. N., Abraham, G. E., & Buster, J. E. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57542-6 · Cited by 81 · cited 1×
“Casson, 1995 (30) United States, academic hospital 11 Healthy postmenopausal”
BackgroundIgwebuike, A., Irving, B. A., Bigelow, M. L., Short, K. R., McConnell, J. P., & Nair, K. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1027 · Cited by 71 · cited 1×
“placebo Igwebuike, 2008 (34) United States, academic hospital 31 Sedentary,”
BackgroundDehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone
Weiss, E. P., Shah, K. N., Fontana, L., Lambert, C. P., Holloszy, J. O., & Villareal, D. T. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27265 · Cited by 69 · cited 1×
“Weiss, 2009 (41) United States, academic hospital 58 Healthy postmenopausal”
BackgroundBarnhart, K. T., Freeman, E., Grisso, J. A., Rader, D. J., Sammel, M., Kapoor, S., & Nestler, J. E. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200004000-00020 · Cited by 62 · cited 1×
“Barnhart, 1999 (27) United States, academic hospital 66 Perimenopausal women”
BackgroundPanjari, M., Bell, R. J., Jane, F., Wolfe, R. S., Adams, J., Morrow, C., & Davis, S. R. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01381.x · Cited by 61 · cited 5×
“3540 Elraiyah et al DHEA in Postmenopausal Women J Clin Endocrinol Metab, October 2014, 99(10):3536–3542”
BackgroundMethodInfluentialThe safety of 52 weeks of oral DHEA therapy for postmenopausal women
Panjari, M., Bell, R. J., Jane, F., Adams, J., Morrow, C., & Davis, S. R. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.020 · Cited by 56 · cited 1×
“Panjari, 2009 (10, 38) Australia, academic hospital 93 Healthy postmenopausal”
BackgroundA randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.
Finckh, A., Berner, I. C., Aubry‐Rozier, B., & So, A. K.-L. (2005) · PubMed · Cited by 45
Supplementation with DHEA: Effect on Muscle Size, Strength, Quality of Life, and Lipids
Dayal, M., Sammel, M. D., Zhao, J., Hummel, A. C., Vandenbourne, K., & Barnhart, K. T. (2005) · Journal of Women's Health · doi:10.1089/jwh.2005.14.391 · Cited by 42 · cited 1×
“Dayal, 2005 (31) United States, academic hospital 50 Healthy postmenopausal”
BackgroundGómez‐Santos, C., Morante, J. J. H., Tébar, F. J., Granero, E., & Garaulet, M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04306.x · Cited by 31 · cited 1×
“Gómez-Santos, 2012 (33) Spain, academic hospital 61 Healthy postmenopausal”
BackgroundBloch, M., Meiboom, H., Zaig, I. F., Schreiber, S., & Abramov, L. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.004 · Cited by 28 · cited 1×
“Bloch, 2013 (28) Israel, academic hospital 25 Health postmenopausal”
BackgroundSrinivasan, M., Irving, B. A., Frye, R. L., O'Brien, P., Hartman, S. J., McConnell, J. P., & Nair, K. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2000 · Cited by 22 · cited 1×
“Srinivasan, 2010 (39) United States, academic hospital 57 Healthy postmenopausal”
BackgroundCarranza‐Lira, S., Jl, N. M., Herrera, J., Ramos-Ponce, D., Olivares, A., Cardoso-Saldaña, G. C., & Posadas‐Romero, C. (2002) · PubMed · Cited by 9
Cited by
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2260 · Cited by 363
Self-citationThe physiology of endocrine systems with ageing
van den Beld, A. W., Kaufman, J.-M., Zillikens, M. C., Lamberts, S. W. J., Egan, J. M., & van der Lely, A. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30026-3 · Cited by 349
Menopause—Biology, consequences, supportive care, and therapeutic options
Davis, S. R., Pinkerton, J., Santoro, N., & Simoncini, T. (2023) · Cell · doi:10.1016/j.cell.2023.08.016 · Cited by 233
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
Davis, S. R., Baber, R., Panay, N., Bitzer, J., Perez, S. C., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01603 · Cited by 270
Metadata
- Authors
- Elraiyah, T., Sonbol, M. B., Wang, Z., Khairalseed, T., Asi, N., Undavalli, C., Nabhan, M., Altayar, O., Prokop, L., Montori, V. M., & Murad, M. H.
- Affiliations
- Mayo Clinic (US)
- Augusta University (US)
- Knowledge and Evaluation Research Unit (T.E., M.B.S., Z.W., T.K., N.A., C.U., M.N., O.A., V.M.M., M.H.M.), Rochester, Minnesota 55905
- Corresponding author
- Murad, Mohammad Hassan
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-10-01
- Volume
- 99
- Issue
- 10
- Pages
- 3536-3542
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5393492
- OpenAlex
- W2026741948
- Cited by
- 97
- References
- 45
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 19 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 1
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000135)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- dehydroepiandrosterone, postmenopausal women, menopausal symptoms, sexual function, sexual desire, adrenal function, serum lipids, serum glucose, body mass index, bone mineral density, adverse effects
- MeSH terms
- Adjuvants, Immunologic, Adrenal Glands, Aging, Dehydroepiandrosterone, Female, Humans, Middle Aged, Randomized Controlled Trials as Topic, Postmenopause, Sexuality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.